AbbVie

AbbVie’s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas –immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on X, Facebook, Instagram, YouTube, LinkedIn and Tik Tok.

1 North Waukegan Road
North Chicago, IL 60064

Visit website

Stock Symbol: ABBV
Stock Exchange: NYSE

Together, we break through.

Our principles are at the Heart of our Company. Operating as one AbbVie team, we care deeply for our patients, their families, our employees, and our communities. We strive to always do the right thing, pursuing the highest standards in quality, compliance, safety, and performance. In everything we do, we invest and innovate relentlessly to tackle unmet needs, creating new medicines and healthcare approaches for a healthier world.

How we work with each other and achieve results matters. That’s why we’ve been honored to receive some of the most prestigious ratings and recognitions in the industry, including being named on more than 40 Great Place to Work and Top Employer lists and FORTUNE “100 Best Companies to Work For.”

Click here to learn more about our principles.

NEWS

Bio NC

BioSpace Announces the 2019 Top 30 Life Sciences Ideal Employers

According to the second biennial 2019 Life Sciences Ideal Employer Report by BioSpace, the top three most important attributes cited by life sciences professionals around the world are the opportunity to do interesting and meaningful work, a competitive salary and health benefits.

September 24, 2019

1 min read

BioSpace Staff

Drug Development

Alzheimer’s Disease Insight Report: Current Therapies, Drug Pipeline and Outlook

50 million people worldwide live with symptomatic Alzheimer’s, which has no cure. In honor of September 21st being World Alzheimer’s Day, we evaluated the current therapies, drugs in the pipeline and disease outlook.

September 18, 2019

36 min read

Chelsea Weidman Burke, M.S.

Business

What Makes BioMidwest a Great Place to Live?

The Midwestern region of the United States is often referred to as “flyover country” by residents of both coasts as a way to diminish or dismiss the importance of the states that make up this part of the nation. But the Midwest can be a great place to live and raise a family.

September 9, 2019

4 min read

Alex Keown

Business

Following Rova-T Failure, AbbVie Enters Immuno-Oncology Deal with Idera

Financial terms of the collaboration were not disclosed but shareholders of the Pennsylvania-based company responded favorably.

September 4, 2019

2 min read

Alex Keown

Bio NC

Clinical Catch-Up: August 25-30

Rounding out the traditional summer months, last week had plenty of clinical trial news. Here’s a look at some of the top stories.

August 30, 2019

6 min read

Mark Terry

Drug Development

AbbVie Out $5.8 Billion After Scrapping Rova-T Program

AbbVie announced that the Phase III MERU trial evaluating Rova-T as first-line maintenance therapy for advanced small-cell lung cancer, failed to demonstrate a survival benefit following a pre-planned interim analysis.

August 30, 2019

2 min read

Alex Keown

FDA

FDA Approves AbbVie’s Rinvoq, a Potential Successor to Humira

AbbVie’s JAK inhibitor Rinvoq was approved by the U.S. Food and Drug Administration for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate.

August 19, 2019

3 min read

Alex Keown

BioMidwest

Report: Projected Sales of 10 Top-Selling Drugs Through 2024

Although some of the top-selling drugs in the world are facing patent cliffs between now and then, many of them are still projected to continue being big sellers between now and 2024.

August 16, 2019

3 min read

Mark Terry